查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088895

心臟衰竭檢測 (POC) 和局部檢測 (LOC) 設備市場：按測試類型、設備類型、技術和最終用戶分類－2026-2032 年全球市場預測

Heart Failure POC & LOC Devices Market by Test Type, Device Type, Technology, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，用於治療心臟衰竭的即時檢測和線下檢測設備的市場規模將成長至 7.4492 億美元，複合年成長率為 13.77%。

主要市場統計數據
基準年 2025 3.0192億美元
預計年份：2026年 3.4806億美元
預測年份 2032 7.4492億美元
複合年成長率 (%) 13.77%

用於心臟衰竭的即時檢測 (POC) 和晶片實驗室 (LOC) 設備正從輔助診斷工具轉變為快速分流、風險分層和長期疾病管理的關鍵工具。據報告，全球心臟衰竭患者超過 6,400 萬，而美國疾病管制與預防中心 (CDC) 的數據顯示，約有 670 萬 20 歲及以上的美國成年人患有心臟衰竭，凸顯了快速、分散式檢測的必要性。

該領域的核心是利鈉肽檢測，包括BNP和NT-proBNP，這些檢測已獲得主要臨床指南的支持，用於疑似心臟衰竭的診斷、排除和風險評估。隨著急診科、基層醫療診所、居家照護計畫、門診機構和社區護理團隊對更快決策、減少不必要的住院治療以及加強對高風險患者的監測的需求日益成長，這些檢測的應用範圍也在不斷擴大。

心臟衰竭診斷領域的變革性變化

心臟衰竭診斷領域正朝著分散式、網路化和小型化的檢測方向發展。微流體技術、生物感測器、免疫檢測的小型化以及智慧型手機等技術的進步，正在縮短檢測結果的報告時間，並降低對中心檢查室的依賴，尤其是在需要快速獲得結果的情況下，例如評估緊急呼吸困難、充血以及最佳化治療方案。

人工智慧（AI）的累積影響

人工智慧 (AI) 透過改善訊號處理、檢測結果解讀、風險評分和工作流程優先排序，增強了心臟衰竭的即時檢測 (POC) 和線下檢測 (LOC) 設備。 AI 驅動的分析可以將生物標記值與生命徵象、心電圖模式、合併症、用藥資訊、腎功能指標和歷史使用數據相結合，從而幫助早期發現心臟衰竭補償和高風險症狀。

全球市場主要區域趨勢

北美地區憑藉其成熟的急救醫療網路、高發生率的心臟衰竭病例、完善的保險報銷機制以及強大的數位醫療基礎設施，仍然是該技術應用的主要地區。在歐洲，基於指南的利鈉肽檢測、人口老化、檢查室品質標準以及以醫院和社區為重點的慢性病綜合管理國家項目，正在推動市場成長。

針對特定群體的關鍵洞察，以進行策略市場優先排序

歐盟擁有許多優勢，例如統一的醫療設備法規、大規模的老齡人口、結構化的臨床路徑以及積極採納指南，使其成為檢驗的即時檢測（POC​​）和現場檢測（LOC）心臟衰竭診斷的重要環境。七國集團（G7）在報銷體系的成熟度、臨床研究的活躍程度、品質標準以及慢性心血管疾病互聯主導模式的採用方面均處於領先地位。

主要心臟衰竭市場的具體國家/地區洞察

美國在臨床應用方面處於主導地位，這得益於其在急診醫學領域強大的應用案例、美國疾病控制與預防中心（CDC）認可的疾病負擔、成熟的生物標記檢測實踐以及不斷擴展的遠端監測項目。加拿大優先考慮公平獲取醫療服務和慢性病管理，而墨西哥和巴西則面臨日益嚴重的心血管疾病負擔，並且由於醫療系統需要在中心檢查室之外進行快速分診，因此對價格合理、分散式診斷的需求也在不斷成長。

為行業領導者提供的實用建議

行業領導者應優先考慮經臨床檢驗的檢測方法、快速出具結果、與電子健康記錄的互通性以及在急診、門診、農村和家庭環境中的易用性。將生物標記準確性與連接性、嵌入式品管、網路安全和清晰的臨床決策支援相結合的設備，在符合指南的部署中將具有顯著優勢。

基於證據的市場分析調查方法

調查方法應結合對循環系統、急診醫生、實驗室管理人員、醫療設備開發商、保險公司、採購經理、居家照護服務提供者和數位健康領域相關人員的初步訪談。二次檢驗應包括同儕審查的循環系統文獻、主要學術團體發布的臨床指南、監管資料庫、醫院利用率數據、報銷政策以及世界衛生組織和美國疾病控制與預防中心等公共衛生相關資訊來源。

結論與策略展望

用於心臟衰竭的即時檢測 (POC) 和現場檢測 (LOC) 設備正日益成為快速診斷、精準分診和持續管理這種棘手慢性疾病的核心工具。當快速生物標記檢測與支援協調工作流程、檢驗的人工智慧、品質保證和及時臨床決策的整合式醫療模式相結合時，這些設備的價值才能得到最大程度的發揮。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：心臟衰竭即時偵測與遠端偵測設備市場：依偵測類型分類

  • 基因組檢測
  • 代謝體學學檢測
  • 蛋白質體學檢測

第8章：心臟衰竭即時檢測和遠距醫療設備市場：按設備類型分類

  • 診斷設備
    • 心臟生物標記分析儀
    • 心臟影像影像設備
    • 心電圖（ECG）
  • 穿戴式裝置
    • 體外去心房顫動
    • 心率監測器

第9章：心臟衰竭即時檢測與遠端檢測設備市場：依技術分類

  • 基於生物感測器的系統
  • 基於成像和電阻的平台
  • 免疫測量
  • 基於核酸的平台

第10章：心臟衰竭即時偵測與遠端偵測設備市場：依最終使用者分類

  • 輔助生活醫療保健
  • 居家照護設施
  • 醫院和診所
  • 檢查室

第11章：心臟衰竭即時偵測與遠端偵測設備市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章：心臟衰竭即時偵測與遠端偵測設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：心臟衰竭即時偵測與遠端偵測設備市場：按國家/地區分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Abbott Laboratories
  • ACON Laboratories Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Boston Scientific Corporation
  • Cipla Limited
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Fukuda Denshi Co., Ltd.
  • Jant Pharmacal Corporation
  • Johari Digital India Limited by Syrma SGS
  • Koninklijke Philips NV
  • LifeSign LLC
  • LifeSync
  • Luminex Corporation by DiaSorin SpA
  • Mitsubishi Chemical Group Corporation
  • Nexus Dx, Inc
  • Nihon Kohden Corporation
  • Quidel Corporation
  • Schiller AG
  • Shenzhen EDAN Instrument Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers AG
  • Spectral Diagnostics Inc.
  • Trinity Biotech PLC
Product Code: MRR-CA17E905EA91

The Heart Failure POC & LOC Devices Market is projected to grow by USD 744.92 million at a CAGR of 13.77% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 301.92 million
Estimated Year [2026] USD 348.06 million
Forecast Year [2032] USD 744.92 million
CAGR (%) 13.77%

Heart failure point-of-care (POC) and lab-on-chip (LOC) devices are moving from adjunct diagnostics to essential tools for faster triage, risk stratification, and longitudinal disease management. Global heart failure prevalence is commonly reported at more than 64 million people, while the CDC reports that approximately 6.7 million U.S. adults aged 20 and older live with heart failure, underscoring the need for rapid, decentralized testing.

The field is anchored by natriuretic peptide testing, including BNP and NT-proBNP, which is supported by major clinical guidelines for diagnosis, exclusion, and risk assessment in suspected heart failure. Adoption is expanding as emergency departments, primary care clinics, home care programs, ambulatory settings, and community-based care teams seek faster decisions, fewer avoidable admissions, and improved monitoring of high-risk patients.

Transformative Shifts in the Heart Failure Diagnostics Landscape

The heart failure diagnostics landscape is shifting toward decentralized, connected, and miniaturized testing. Microfluidics, biosensors, immunoassay miniaturization, and smartphone-enabled readers are improving turnaround time and reducing dependence on centralized laboratories, especially where urgent dyspnea evaluation, congestion assessment, and therapy optimization require fast results.

Healthcare systems are also prioritizing value-based care, hospital-at-home models, and remote patient monitoring. These shifts support integrated heart failure pathways where POC and LOC devices work alongside echocardiography, ECG, wearable sensors, electronic health records, and guideline-directed medical therapy to reduce diagnostic delays and support timely escalation or de-escalation of care.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is strengthening heart failure POC and LOC devices by improving signal processing, assay interpretation, risk scoring, and workflow prioritization. AI-enabled analytics can combine biomarker values with vital signs, ECG patterns, comorbidities, medications, renal function indicators, and prior utilization data to support earlier identification of decompensation and higher-risk presentations.

The cumulative impact is most valuable when algorithms are clinically validated, explainable, bias-assessed, and integrated into physician-supervised workflows. Regulatory expectations from guidance on software as a medical device, good machine learning practice, cybersecurity, data governance, and post-market monitoring are shaping responsible deployment across connected heart failure diagnostics.

Key Regional Insights Across Global Markets

North America remains a leading adoption region due to mature emergency care networks, high heart failure burden, established reimbursement pathways, and strong digital health infrastructure. Europe is driven by guideline-based natriuretic peptide testing, aging populations, laboratory quality standards, and national programs focused on integrated chronic disease care across hospital and community settings.

Asia-Pacific is expanding as China, India, Japan, South Korea, and Australia invest in diagnostics access, connected care, local manufacturing, and chronic cardiovascular disease management. Latin America shows demand for cost-effective POC testing in urban hospitals, public health systems, and underserved areas, while the Middle East is advancing premium hospital infrastructure, digital transformation, and specialist cardiovascular services. Africa presents long-term opportunity where portable diagnostics can improve access to heart failure assessment despite workforce shortages, fragmented referral systems, and limited centralized laboratory capacity.

Key Group Insights for Strategic Market Prioritization

The European Union benefits from harmonized medical device regulation, large aging populations, structured clinical pathways, and strong guideline adoption, making it an important environment for validated POC and LOC heart failure diagnostics. G7 countries lead in reimbursement maturity, clinical research intensity, quality standards, and adoption of connected care models for chronic cardiovascular disease.

BRICS markets are important for scalable access, local production, and affordable testing models suited to large and diverse patient populations. ASEAN countries are prioritizing diagnostics access, mobile health integration, and primary care strengthening, while GCC systems are investing in advanced hospital networks, digital transformation, and chronic disease programs. NATO member markets add relevance through procurement resilience, cybersecurity expectations, interoperability, and secure medical infrastructure for connected diagnostic platforms.

Key Country Insights Across Major Heart Failure Markets

The United States leads in clinical adoption due to strong emergency medicine use cases, CDC-recognized disease burden, established biomarker testing practices, and growing remote monitoring programs. Canada emphasizes equitable access and chronic disease management, while Mexico and Brazil show rising need for affordable decentralized diagnostics as cardiovascular disease burdens expand and health systems seek faster triage outside centralized laboratories.

In Europe, the United Kingdom, Germany, France, Italy, and Spain support evidence-based natriuretic peptide testing through guideline-led care pathways, aging populations, and established hospital networks, while Russia faces a need for scalable diagnostics across dispersed populations and variable regional access. China and India are priority growth environments due to population size, urban hospital expansion, and improving diagnostics access; Japan, South Korea, and Australia are advanced adopters shaped by aging demographics, sophisticated hospitals, quality-focused regulation, and digital health readiness.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated assays, fast turnaround time, interoperability with electronic health records, and usability across emergency, outpatient, rural, and home-based settings. Devices that combine biomarker accuracy with connectivity, embedded quality controls, cybersecurity, and clear clinical decision support will be better positioned for guideline-aligned adoption.

Organizations should build evidence packages demonstrating diagnostic performance, workflow impact, reduced time to treatment, readmission-related outcomes, and health economic value. Partnerships with hospitals, payers, home care providers, emergency networks, and public health systems can accelerate procurement, while localized pricing, service support, training, and manufacturing strategies can improve access in emerging markets.

Research Methodology for Evidence-Based Market Analysis

The research methodology should combine primary interviews with cardiologists, emergency physicians, laboratory directors, device developers, payers, procurement leaders, home care providers, and digital health stakeholders. Secondary validation should include peer-reviewed cardiology literature, clinical guideline statements from major societies, regulatory databases, hospital utilization data, reimbursement policies, and public health sources such as WHO and CDC.

Market interpretation should triangulate clinical demand, installed care pathways, reimbursement readiness, diagnostic accuracy requirements, technology maturity, regional access gaps, regulatory expectations, and competitive positioning. This approach supports defensible, evidence-based insights without relying on unsupported projections and helps identify where POC and LOC devices can create measurable clinical and operational value.

Conclusion and Strategic Outlook

Heart failure POC and LOC devices are becoming central to faster diagnosis, targeted triage, and continuous management of a high-burden chronic condition. Their value is strongest when rapid biomarker testing is paired with connected workflows, validated AI, quality assurance, and integrated care models that support timely clinical decisions.

The strategic outlook is supported by aging populations, rising cardiovascular disease prevalence, emergency department pressure, and health system efforts to reduce avoidable admissions. Organizations that deliver accurate, affordable, interoperable, secure, and clinically trusted solutions will be well positioned to shape the next phase of decentralized heart failure care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Heart Failure POC & LOC Devices Market, by Test Type

  • 7.1. Genomic Testing
  • 7.2. Metabolomic Testing
  • 7.3. Proteomic Testing

8. Heart Failure POC & LOC Devices Market, by Device Type

  • 8.1. Diagnostic Devices
    • 8.1.1. Cardiac Biomarker Analyzers
    • 8.1.2. Cardiac Imaging Devices
    • 8.1.3. Electrocardiogram (ECG)
  • 8.2. Wearable Devices
    • 8.2.1. External Defibrillator
    • 8.2.2. Heart Rate Monitors

9. Heart Failure POC & LOC Devices Market, by Technology

  • 9.1. Biosensor-based systems
  • 9.2. Imaging & impedance-based platforms
  • 9.3. Immunoassays
  • 9.4. Nucleic acid-based platforms

10. Heart Failure POC & LOC Devices Market, by End User

  • 10.1. Assisted Living Healthcare
  • 10.2. Home Care Facilities
  • 10.3. Hospitals & Clinics
  • 10.4. Laboratory

11. Heart Failure POC & LOC Devices Market, by Region

  • 11.1. Asia-Pacific
  • 11.2. North America
  • 11.3. Latin America
  • 11.4. Europe
  • 11.5. Middle East
  • 11.6. Africa

12. Heart Failure POC & LOC Devices Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Heart Failure POC & LOC Devices Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Concentration Analysis, 2025
    • 14.1.1. Concentration Ratio (CR)
    • 14.1.2. Herfindahl Hirschman Index (HHI)
  • 14.2. Recent Developments & Impact Analysis, 2025
  • 14.3. Product Portfolio Analysis, 2025
  • 14.4. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Abbott Laboratories
  • 15.2. ACON Laboratories Inc.
  • 15.3. Becton, Dickinson and Company
  • 15.4. Bio-Rad Laboratories, Inc.
  • 15.5. bioMerieux S.A.
  • 15.6. Boston Scientific Corporation
  • 15.7. Cipla Limited
  • 15.8. Danaher Corporation
  • 15.9. F. Hoffmann-La Roche Ltd.
  • 15.10. Fukuda Denshi Co., Ltd.
  • 15.11. Jant Pharmacal Corporation
  • 15.12. Johari Digital India Limited by Syrma SGS
  • 15.13. Koninklijke Philips N.V.
  • 15.14. LifeSign LLC
  • 15.15. LifeSync
  • 15.16. Luminex Corporation by DiaSorin S.p.A.
  • 15.17. Mitsubishi Chemical Group Corporation
  • 15.18. Nexus Dx, Inc
  • 15.19. Nihon Kohden Corporation
  • 15.20. Quidel Corporation
  • 15.21. Schiller AG
  • 15.22. Shenzhen EDAN Instrument Co., Ltd.
  • 15.23. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 15.24. Siemens Healthineers AG
  • 15.25. Spectral Diagnostics Inc.
  • 15.26. Trinity Biotech PLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GENOMIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GENOMIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GENOMIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL METABOLOMIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL METABOLOMIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL METABOLOMIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PROTEOMIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PROTEOMIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PROTEOMIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DIAGNOSTIC DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DIAGNOSTIC DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DIAGNOSTIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC BIOMARKER ANALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC BIOMARKER ANALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CARDIAC BIOMARKER ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CARDIAC IMAGING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CARDIAC IMAGING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CARDIAC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ELECTROCARDIOGRAM (ECG) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ELECTROCARDIOGRAM (ECG) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ELECTROCARDIOGRAM (ECG) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL WEARABLE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL WEARABLE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL WEARABLE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL EXTERNAL DEFIBRILLATOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL EXTERNAL DEFIBRILLATOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL EXTERNAL DEFIBRILLATOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HEART RATE MONITORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HEART RATE MONITORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HEART RATE MONITORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOSENSOR-BASED SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIOSENSOR-BASED SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOSENSOR-BASED SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL IMAGING & IMPEDANCE-BASED PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL IMAGING & IMPEDANCE-BASED PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL IMAGING & IMPEDANCE-BASED PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL IMMUNOASSAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL IMMUNOASSAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NUCLEIC ACID-BASED PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NUCLEIC ACID-BASED PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NUCLEIC ACID-BASED PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ASSISTED LIVING HEALTHCARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ASSISTED LIVING HEALTHCARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ASSISTED LIVING HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HOME CARE FACILITIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HOME CARE FACILITIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HOME CARE FACILITIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL LABORATORY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL LABORATORY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL LABORATORY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 101. AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. GCC HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 112. GCC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. GCC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. GCC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 115. GCC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 116. GCC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. GCC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPEAN UNION HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. BRICS HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. G7 HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 133. G7 HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. G7 HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. G7 HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 136. G7 HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 137. G7 HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. G7 HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. NATO HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. NATO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. NATO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. NATO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 143. NATO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 144. NATO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. NATO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 151. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 152. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 158. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 159. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 162. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 165. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 166. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 169. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 172. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 173. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 174. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 183. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 186. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 187. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 188. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 193. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 194. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 200. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 201. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 204. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 207. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 208. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 211. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 214. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 215. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 216. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 225. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 228. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 229. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 230. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 232. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 235. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 236. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 237. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 239. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 242. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 243. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 244. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 249. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 250. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 251. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)